Paper28056859
Molecular chess? Hallmarks of anti-cancer drug resistance.
Cree IA and 1 other. BMC Cancer, 2017. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. Molecular chess? Hallmarks of anti-cancer drug resistance. Papers, record 28056859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28056859
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance, Neoplasm | Major topic |
| Medical Oncology | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Precision Medicine |
Source PubMed
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23562214 | Molecular determinants of trastuzumab efficacy: What is their clinical relevance? | Cancer Treat Rev | 2013 | https://conductscience.org/library/papers/23562214 | PubMed |
| 2 | 26142874 | Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside. | Cancer Treat Rev | 2015 | https://conductscience.org/library/papers/26142874 | PubMed |
| 3 | 7014501 | Cell death: the significance of apoptosis. | Int Rev Cytol | 1980 | https://conductscience.org/library/papers/7014501 | PubMed |
| 4 | 15930355 | Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15930355 | PubMed |
| 5 | 26358176 | A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance. | Cancer Gene Ther | 2015 | https://conductscience.org/library/papers/26358176 | PubMed |
| 6 | 20078251 | Glutathione S-transferases: an overview in cancer research. | Expert Opin Drug Metab Toxicol | 2010 | https://conductscience.org/library/papers/20078251 | PubMed |
| 7 | 25143300 | Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. | Cancer Chemother Pharmacol | 2015 | https://conductscience.org/library/papers/25143300 | PubMed |
| 8 | 24152759 | Tumor hypoxia as a driving force in genetic instability. | Genome Integr | 2013 | https://conductscience.org/library/papers/24152759 | PubMed |
| 9 | 19371598 | Anti- and pro-tumor functions of autophagy. | Biochim Biophys Acta | 2009 | https://conductscience.org/library/papers/19371598 | PubMed |
| 10 | 27532023 | PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction? | J Immunother Cancer | 2016 | https://conductscience.org/library/papers/27532023 | PubMed |
| 12 | 24193010 | A comparison of methods for EGFR mutation testing in non-small cell lung cancer. | Diagn Mol Pathol | 2013 | https://conductscience.org/library/papers/24193010 | PubMed |
| 13 | 1735085 | Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer. | Cancer | 1992 | https://conductscience.org/library/papers/1735085 | PubMed |
| 14 | 24531699 | The GIST of targeted therapy for malignant melanoma. | Ann Surg Oncol | 2014 | https://conductscience.org/library/papers/24531699 | PubMed |
| 15 | 26830315 | Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions. | Drug Resist Updat | 2016 | https://conductscience.org/library/papers/26830315 | PubMed |
| 16 | 24489728 | Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor. | PLoS One | 2014 | https://conductscience.org/library/papers/24489728 | PubMed |
| 17 | 19495754 | Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences. | Cancer Chemother Pharmacol | 2010 | https://conductscience.org/library/papers/19495754 | PubMed |
| 18 | 25765070 | Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. | Science | 2015 | https://conductscience.org/library/papers/25765070 | PubMed |
| 19 | 24022196 | Targeting EGFR and PI3K pathways in ovarian cancer. | Br J Cancer | 2013 | https://conductscience.org/library/papers/24022196 | PubMed |
| 20 | 16026610 | Cancer cell adaptation to chemotherapy. | BMC Cancer | 2005 | https://conductscience.org/library/papers/16026610 | PubMed |
| 21 | 19712441 | Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). | BMC Cancer | 2009 | https://conductscience.org/library/papers/19712441 | PubMed |
Cited by146
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984801 | Pan-cancer multi-omics profiling of SRPK1 identifies tumour-specific associations with prognosis and predicted chemotherapy response in breast, colon and prostate cancer. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42984801 | PubMed |
| 42277467 | Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42277467 | PubMed |
| 42266673 | A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial). | Front Oncol | 2026 | https://conductscience.org/library/papers/42266673 | PubMed |
| 42159875 | Role of the MDM2/p53 axis in regulating cisplatin response in tumor cells. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42159875 | PubMed |
| 42083452 | Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate Cancer. | Mol Cancer Ther | 2026 | https://conductscience.org/library/papers/42083452 | PubMed |
| 41977308 | Mechanisms Underlying Cancer Chemoresistance: A Starting Point to Identify New Anticancer Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977308 | PubMed |
| 41484230 | Migrastatic therapy as a potential game-changer in adaptive cancer treatment. | Sci Rep | 2026 | https://conductscience.org/library/papers/41484230 | PubMed |
| 41413149 | In vitro and in silico evaluation of flavonoids from Erythrina crista-galli with cytotoxic potential against MCF-7 breast cancer cell. | Sci Rep | 2025 | https://conductscience.org/library/papers/41413149 | PubMed |
| 41321380 | Epithelial-mesenchymal dynamics in cancer: Role of signalling pathways, stromal interactions and natural therapies. | ADMET DMPK | 2025 | https://conductscience.org/library/papers/41321380 | PubMed |
| 41205803 | Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation. | J Adv Res | 2026 | https://conductscience.org/library/papers/41205803 | PubMed |
| 41009436 | Transcriptomic and Cytogenetic Analysis of Oxaliplatin-Resistant Colorectal Adenocarcinoma HCT116 Cells to Identify Markers Associated with Platinum Resistance. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009436 | PubMed |
| 40867879 | Development and In Vitro Cytotoxicity Evaluation of Individual and Combined Injectable Solutions of Curcumin and Resveratrol Against Lung Cancer Cells. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40867879 | PubMed |
| 40859967 | Traditional Chinese Medicine Monomers and Their Derivatives as a Promising Therapeutic Tool for Hepatocellular Carcinoma by Activation of Mitophagy. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40859967 | PubMed |
| 40332396 | Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332396 | PubMed |
| 40330561 | Algae-Mediated Green Synthesis of Dextran-Coated Titanium Nanoparticles and Their Cytotoxic Potential Against MCF7 Breast Cancer Cells. | Rep Biochem Mol Biol | 2024 | https://conductscience.org/library/papers/40330561 | PubMed |
| 40282556 | Aberrant Splicing as a Mechanism for Resistance to Cancer Therapies. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40282556 | PubMed |
| 40260304 | Circulating tumor cell markers for early detection and drug resistance assessment through liquid biopsy. | Front Oncol | 2025 | https://conductscience.org/library/papers/40260304 | PubMed |
| 40212121 | Permanently Charged Cationic Lipids-Evolution from Excipients to Therapeutic Lipids. | Small Sci | 2024 | https://conductscience.org/library/papers/40212121 | PubMed |
| 40164749 | Identification of drug-resistant individual cells within tumors by semi-supervised transfer learning from bulk to single-cell transcriptome. | Commun Biol | 2025 | https://conductscience.org/library/papers/40164749 | PubMed |
| 40149313 | An Overview of Cellular and Molecular Determinants Regulating Chemoresistance in Pleural Mesothelioma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40149313 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28056859
GET https://conductscience.org/api/papers/v1/28056859/references?page=2